FP7
COMBACTE-CARE
Combatting Bacterial Resistance in Europe - Carbapenem Resistance
- Programme
- Seventh Framework Programme
- Started
- Ends
- Duration
- 60 months
- Total cost
- EUR 85,113,336
- EU contribution
- EUR 23,871,500
- Participants
- 21 from 11 countries
- Topic
- FP7_IMI-JU-09-2013-04
- Grant agreement
- 115620
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Universiteit Antwerpen | BEBelgium | Participant | EUR 1,209,313 | known name (0.95) |
| Basilea Pharmaceutica International AG | CHSwitzerland | Participant | Not stated | PIC (1.00) |
| Universite de Geneve | CHSwitzerland | Participant | EUR 162,664 | known name (0.95) |
| Klinikum der Universitaet Zu Koeln | DEGermany | Participant | EUR 2,094,471 | PIC (1.00) |
| Universitaet Ulm | DEGermany | Participant | EUR 121,000 | PIC (1.00) |
| Universitaetsklinikum Freiburg | DEGermany | Participant | EUR 253,000 | PIC (1.00) |
| Fundacion Privada Instituto de Salud Global Barcelona | ESSpain | Participant | EUR 218,962 | known name (0.95) |
| Servicio Andaluz de la Salud | ESSpain | Participant | EUR 4,104,556 | VAT number (0.97) |
| Servicio Madrileno de Salud | ESSpain | Participant | EUR 176,900 | known name (0.97) |
| Centre hospitalier universitaire de Limoges | FRFrance | Participant | EUR 2,614,190 | known name (0.95) |
| Institut National de la Sante et de la Recherche Medicale | FRFrance | Participant | EUR 532,800 | known name (0.95) |
| Cardiff University | GBUnited Kingdom | Participant | EUR 211,039 | known name (0.95) |
| Glaxosmithkline Research & Development Limited | GBUnited Kingdom | Participant | Not stated | PIC (1.00) |
| St George's Hospital Medical School | GBUnited Kingdom | Participant | EUR 247,500 | PIC (1.00) |
| Ethniko Kai Kapodistriako Panepistimio Athinon | GRGreece | Participant | EUR 698,000 | PIC (1.00) |
| The Foundation for Medical Research Infrastructural Development and Health Services Next to the Medical Center Tel Aviv | ILIsrael | Participant | EUR 888,092 | PIC (1.00) |
| The Health Corporation - Rambam | ILIsrael | Participant | EUR 522,200 | PIC (1.00) |
| Academisch Ziekenhuis Groningen | NLNetherlands | Participant | Not stated | PIC (1.00) |
| Universitair Medisch Centrum Utrecht | NLNetherlands | Participant | EUR 9,521,813 | known name (0.95) |
| Astrazeneca AB | SESweden | Participant | Not stated | PIC (1.00) |
| Ministria e Shendetesise | XKKosovo | Participant | EUR 45,000 | PIC (1.00) |
Changes of the consortium
First seen on with 21 participants from 11 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.